Skip to content
★ Sign in to follow
PJ

Petrus Jurgens Myburgh

Mediclinic International plc
Total declarations
6
Company
1
▲ Purchases (3 ops.)
€180k
▼ Sales (0 ops.)
—

Latest filing published 18 Jun 2018 for Mediclinic International plc.

Filing timeline

BuySale
Petrus Jurgens Myburgh

Insider track record

Disclosed buys
3
Disclosed sells
0
Signal history

Closed purchases

Market purchases
3

Not enough history yet: 0 closed purchases, at least 2 are needed.

Purchases by company

Petrus Jurgens Myburgh: trading record in brief

Petrus Jurgens Myburgh is a declared insider of Mediclinic International plc, with filings sourced from RNS (LSE). We count 6 filings; the first trade dates from 14 November 2016 and the latest from 15 June 2018.

Purchases make up the whole of the open-market record (3 purchases, €180k). A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Besides market trades, the filings include 3 share grants.

In size, the median ticket on the buying side is €34k. Clusters matter here: 1 out of 3 purchases overlapped with buying by a colleague within 30 days. Purchases made close together by different insiders form what is called a cluster.

The newest entry dates from 18 June 2018: a share grant, in Mediclinic International plc. The clock since the last published purchase (23 November 2017) now reads 3,273 days. The median gap between a trade and its publication by RNS (LSE) is 2 days. The legal deadline for notifying a trade is three business days (UK MAR). These figures are compiled from regulatory filings published by RNS (LSE). They describe what insiders did and are not a recommendation.

Companies and markets linked to Petrus Jurgens Myburgh

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations6 total
  • ◆
    Chief Financial Officer of the CompanyExecutivesMediclinic International plc
    0FCA-NSM
    137,882 sharesOutside a trading venueISIN GB00B8HX8Z88FCA-NSM:LSE20180618110001_13683487_20200330111423752_12473-1
  • ▲
    Chief Financial Officer of the CompanyExecutivesMediclinic International plc
    30,210 GBP21FCA-NSM
    30,000 shares@ £1.00718.9% of flowJohannesburg Stock ExchangeISIN GB00B8HX8Z88FCA-NSM:LSE20171123150002_13442328_20200330131534853_19663
    Canonical exit: 19 Feb 2018 (T+90)
  • ▲
    Chief Financial Officer of the CompanyExecutivesMediclinic International plc
    19,880 GBP20FCA-NSM
    16,000 shares@ £1.242512.5% of flowJohannesburg Stock ExchangeISIN GB00B8HX8Z88FCA-NSM:LSE20170628160001_13276652_20200330131523447_23008
    Canonical exit: 24 Sept 2017 (T+90)
  • ◆
    Chief Financial Officer of the CompanyExecutivesMediclinic International plc
    0FCA-NSM
    65,263 sharesJohannesburg Stock ExchangeISIN GB00B8HX8Z88FCA-NSM:LSE20170602160001_13248228_20200330131521958_2519-1
  • ◆
    Chief Financial Officer of the CompanyExecutivesMediclinic International plc
    0FCA-NSM
    10,815 sharesJohannesburg Stock ExchangeISIN GB00B8HX8Z88FCA-NSM:LSE20170602160000_13248226_20200330131521957_2517-1
  • ▲
    Chief Financial Officer of the CompanyExecutivesMediclinic International plc
    2M ZAR38FCA-NSM
    14,000 shares@ ZAR 136.4668.5% of flowJohannesburg Stock ExchangeISIN GB00B8HX8Z88FCA-NSM:LSE20161115161502_013035995_20200330143612433_12428
    Canonical exit: 12 Feb 2017 (T+90)

6 of 6 declarations